Medicalsystem Biotechnology Co.,Ltd.’s Net Profit Rose 12.1% in First Three Quarters of 2023

Medicalsystem Biotechnology Co.,Ltd. (美康生物科技股份有限公司) (300439.SZ) reported a net profit of 223.6 million yuan in the first three quarters of 2023, up 12.1% year-on-year.

Meanwhile, the company posted 1.5 billion yuan in revenue, down 22.6% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 883.8 million yuan in total liabilities, with a liability-to-asset ratio of 24.8%.